FPT
Global IT corporation FPT recently signed a Memorandum of Understanding (MoU) with the multinational industrial technology conglomerate Siemens, fostering collaboration and mutually beneficial business opportunities in advancing the manufacturing sector and semiconductor chip production while accelerating digital transformation globally.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228584022/en/
Nguyen The Phuong, Executive Vice President and Chief Finance Officer of FPT Corporation (L), Pham Thai Lai, President & CEO of Siemens ASEAN & Vietnam (R), and both parties’ representatives. (Photo: Business Wire)
FPT and Siemens will join forces in areas such as smart infrastructure, green and intelligent data centers, digital industrial solutions, automotive software development, and digital transformation. Built on the successful partnership on MindSphere IoT Operating System since 2017, the new agreement focuses on strengthening engagement and competencies in digital transformation services for both sides and their clients worldwide, as well as opening up new business opportunities.
Harnessing FPT's robust expertise and high-quality workforce, FPT aspires to become the Global SI Partner for Siemens’ low-code platform - Mendix, and Engineering Services Provider for Siemens EDA, focusing on AUTOSAR projects.
Siemens also invites FPT to join its Xcelerator ecosystem to accelerate digital transformation with Siemens' solutions and applications. Additionally, the two parties will further expand collaboration in the smart infrastructure domain, with Siemens targeting to be the preferred supplier for FPT’s data center network and its sustainable infrastructure development projects in Vietnam.
Leveraging its profound technology foundation in the digital ecosystem, Cloud, and low-code, Siemens commits to aiding FPT with access to training and knowledge-sharing on a large scale. The German powerhouse will also provide support and explore collaboration with FPT in semiconductor design and manufacturing, one of FPT’s pivotal areas for future growth. As a leading chipmaking company in Vietnam, FPT also aims to supply semiconductor chips to Siemens.
Speaking at the signing ceremony, Dr. Truong Gia Binh, FPT Chairman & Founder, said: “FPT focuses on five keywords: Digital transformation, Green transformation, Artificial Intelligence, Automotive, and Semiconductor. Our greatest resource is our talented people, with 32,000 digital transformation experts working across the globe. In the future, we plan to invest in AI supercomputers and workforce training and development, prioritizing NVIDIA certifications and advancing innovations in industries such as automotive and semiconductor. I believe these will be the stepping stones to enhance cooperation between FPT and Siemens.”
Mr. Roland Busch, Chairman and CEO of Siemens AG, affirmed that FPT and Siemens have many commonalities: “Siemens has extensive experience in the semiconductor industry, and we are confident in our capability to provide FPT with technological support. Furthermore, Siemens boasts expertise in various domains, including smart infrastructure and digital industrial solutions. We are positioned to leverage these technologies to enhance product adaptability in daily life. Consequently, Siemens is fully prepared to collaborate closely with FPT in their future endeavors, offering comprehensive support and innovative solutions.”
Siemens and FPT have years of experience in successful collaboration, varying across sectors and industries. With a track record of success and extensive experience, FPT has established itself as a world-class technology enabler for complex business challenges and opportunities. Post surpassing one billion USD in revenue from global IT services in 2023, the Vietnam-headquartered tech corporation aims to achieve USD 5 billion in revenue from global IT services by 2030 and reach billion-dollar milestones from a single market, a single vertical industry and a single contract.
The signing ceremony took place in Hanoi, Vietnam, on 26 February 2024, with the participation of Dr. Roland Busch, Siemens AG President & Chief Executive Officer; Dr. Pham Thai Lai, President & Chief Executive Officer of Siemens ASEAN & Vietnam; Dr. Truong Gia Binh, FPT Corporation Chairman, Mr. Nguyen The Phuong, FPT Corporation Executive Vice President and Chief Finance Officer, as well as both companies’ senior leaders.
About FPT Corporation
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of US$2.17 billion and 70,000+ employees. For more information, please visit https://fpt.com.vn/en.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228584022/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom